Centers for Disease Control and Prevention (CDC), Procurement & Grants Office, Contract Management Branch, 255 East Paces Ferry Rd, NE, Rm 500, Atlanta, GA 30305

B -- MEDICAL AND HEALTH STUDIES SOL 98S266(Q) DUE 073098 POC Anne Wright, Purchasing Agent, (404) 842-6771 The Centers for Disease Control and Prevention intends to negotiate with and award a contract to The Mayo Medical School, Mayo Clinic, to analyze a longitudinal community cohort study database entitled "The Rochester Epidemiology Project (REP). The history surrounding the REP data study encompasses more than fifty years collection on the population of Rochester, Minnesota which has experienced an extremely low rate of mobility making information easily available from birth to adulthood to mortality. The quality of the data is very rare and encompasses a population that is geographically isolated with comprehensive medical information on all residents contained in a central file. The Mayo Clinic owns data collected from the REP, and thus has access to the data set. The examination of the relationship of obesity with all-cause and cardiovascular mortality will require a vendor who possesses access to longitudinal data on body mass index, mortality and potential confounders from a good-sized cohort or people with type 2 diabetes mellitus. Data on body mass index should be available at the time of diagnosis of diabetes, approximately a year before diagnosis, and at least on two occasions after diagnosis. Variables from REP that will be used for the analysis will include: age, sex, smoking, date of examination, Body Mass Index (BMI),cholesterol, treatment, medical history, diabetes status, and diabetes duration. The analysis of information obtained from the data set will be secondary, void of any personal identifiers. The resources of the REP provide a rare opportunity to identify and review the medical records of all residents of a geographically-defined population ever assigned a diagnosis of diabetes or diabetes-like condition. The period of performance for the proposed purchase order is eighteen (18) months from date of award. Other than full and open competition is authorized pursuant to FAR Part 6.302-1, Citation 41 U.S.C. (252(C)(1). Minimum qualifications of prospective offerors shall be: 1.) Knowledge to systematically plan and conduct an analysis of the Rochester Epidemiology Project (REP), in addition to having access to the complete database; 2.) Documentation in the form of curriculum vitae which defines education, training and experience and knowledge of diabetes, obesity, cardiovascular disease, public health and chronic diseases; 3.) Writing skills evidenced by publications on diabetes using large data sets in peer-reviewed journals; 4.) Demonstrate knowledge of epidemiology acquired by experience and degree to include five (5) years in public health epidemiology; 5.) The principal investigator shall possess a degree in Medicine with additional training in endocrinology. Prospective offerors will have fifteen (15) calendar days from the date of synopsis to submit capability statements which define offeror's ability to provide services defined herein. Capability Statements, to include Curriculum Vitae for key personnel, may be sent to Anne Wright, at the above address, or via fax at (404)842-6727. Capability statements will be used solely for the purpose of determining whether to conduct a competitive acquisition. This is not an RFQ, and responses will not be acknowledged. A solicitation may or may not be issued as a result of this notice. All responsible sources may submit a capability statement which shall be considered by the agency. Posted 07/09/98. (0190)

Loren Data Corp. http://www.ld.com (SYN# 0015 19980713\B-0007.SOL)